Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1Phase 2 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Tuberous Sclerosis 3Seizures 1Neoplasms 1Epilepsy 1

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Vigabatrin × Clear all
NCT02849457 2024-08-19

Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex

University of Alabama at Birmingham

Phase 2 Completed
84 enrolled 16 charts

Tuberous Sclerosis

NCT04987463 2024-02-08

ViRap

Children's Memorial Health Institute, Poland

Phase 2/3 Unknown
60 enrolled

Epilepsy, Neoplasms, Tuberous Sclerosis

NCT01266291 2017-07-12

STARS

University of Pennsylvania

Phase 4 Terminated
1 enrolled 8 charts

Seizures, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡